相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Rif1 controls DNA replication by directing Protein Phosphatase 1 to reverse Cdc7-mediated phosphorylation of the MCM complex
Shin-ichiro Hiraga et al.
GENES & DEVELOPMENT (2014)
Xenopus Cdc7 executes its essential function early in S phase and is counteracted by checkpoint-regulated protein phosphatase 1
Wei Theng Poh et al.
OPEN BIOLOGY (2014)
Drugging Topoisomerases: Lessons and Challenges
Yves Pommier
ACS CHEMICAL BIOLOGY (2013)
N-substituted azaindoles as potent inhibitors of Cdc7 kinase
Marian C. Bryan et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Cdc7-dependent and -independent phosphorylation of Claspin in the induction of the DNA replication checkpoint
Michael D. Rainey et al.
CELL CYCLE (2013)
ATR-Chk1-APC/CCdh1-dependent stabilization of Cdc7-ASK (Dbf4) kinase is required for DNA lesion bypass under replication stress
Masayuki Yamada et al.
GENES & DEVELOPMENT (2013)
A New Target for an Old Drug: Identifying Mitoxantrone as a Nanomolar Inhibitor of PIM1 Kinase via Kinome-Wide Selectivity Modeling
Xiaobo Wan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Potent DNA damage by polyhalogenated quinones and H2O2 via a metal-independent and Intercalation-enhanced oxidation mechanism
Ruichuan Yin et al.
SCIENTIFIC REPORTS (2013)
MicroRNA-29a regulates the benzo[a]pyrene dihydrodiol epoxide-induced DNA damage response through Cdc7 kinase in lung cancer cells
L. R. Barkley et al.
ONCOGENESIS (2013)
Recent advances on structural modifications of benzothiazoles and their conjugate systems as potential chemotherapeutics
Kamal Ahmed et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2012)
Inhibition of DNA Damage-induced Apoptosis through Cdc7-mediated Stabilization of Tob
Toru Suzuki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Dynamics of DNA damage response proteins at DNA breaks: a focus on protein modifications
Sophie E. Polo et al.
GENES & DEVELOPMENT (2011)
The CDK inhibitors in cancer research and therapy
Jonas Cicenas et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2011)
Mechanisms of Action of a Dual Cdc7/Cdk9 Kinase Inhibitor against Quiescent and Proliferating CLL Cells
Alessandro Natoni et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity
Theonie Anastassiadis et al.
NATURE BIOTECHNOLOGY (2011)
Mining for therapeutic gold
Francis S. Collins
NATURE REVIEWS DRUG DISCOVERY (2011)
A High-Throughput, Cell-Based Screening Method for siRNA and Small Molecule Inhibitors of mTORC1 Signaling Using the In Cell Western Technique
Gregory R. Hoffman et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2010)
DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs
Yves Pommier et al.
CHEMISTRY & BIOLOGY (2010)
Targeting Cell Division Cycle 7 Kinase: A New Approach for Cancer Therapy
Alessia Montagnoli et al.
CLINICAL CANCER RESEARCH (2010)
Cdc7 kinase - A new target for drug development
Ronan Swords et al.
EUROPEAN JOURNAL OF CANCER (2010)
Phosphorylated Rad18 directs DNA Polymerase η to sites of stalled replication
Tovah A. Day et al.
JOURNAL OF CELL BIOLOGY (2010)
Cdc7 Kinase Inhibitors: 5-Heteroaryl-3-Carboxamido-2-Aryl Pyrroles as Potential Antitumor Agents. 1. Lead Finding
Maria Menichincheri et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
The Dbf4-Cdc7 kinase promotes S phase by alleviating an inhibitory activity in Mcm4
Yi-Jun Sheu et al.
NATURE (2010)
Synthesis and evaluation of pyrido-thieno-pyrimidines as potent and selective Cdc7 kinase inhibitors
Chunlin Zhao et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
First Cdc7 Kinase Inhibitors: Pyrrolopyridinones as Potent and Orally Active Antitumor Agents. 2. Lead Discovery
Maria Menichincheri et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Phosphorylation of Mcm2 by Cdc7 Promotes Pre-replication Complex Assembly during Cell-Cycle Re-entry
Li-Chiou Chuang et al.
MOLECULAR CELL (2009)
Transient inhibition of ATM kinase is sufficient to enhance cellular sensitivity to ionizing radiation
Michael D. Rainey et al.
CANCER RESEARCH (2008)
Cdc7 as a Potential New Target for Cancer Therapy
Sayuri Ito et al.
DRUG NEWS & PERSPECTIVES (2008)
Cdc7 kinase inhibitors: Pyrrolopyridinones as potential antitumor agents. 1. Synthesis and structure-activity relationships
Ermes Vanotti et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Assessment of DNA double-strand breaks and γH2AX induced by the topoisomerase II poisons etoposide and mitoxantrone
Daniel J. Smart et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2008)
A Cdc7 kinase inhibitor restricts initiation of DNA replication and has antitumor activity
Alessia Montagnoli et al.
NATURE CHEMICAL BIOLOGY (2008)
Cdc7 kinase mediates Claspin phosphorylation in DNA replication checkpoint
J. M. Kim et al.
ONCOGENE (2008)
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases
Oleg Fedorov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Involvement of centrosome amplification in radiation-induced mitotic catastrophe
Helen Dodson et al.
CELL CYCLE (2007)
Broad-spectrum caspase inhibitors: from myth to reality?
D. Chauvier et al.
CELL DEATH AND DIFFERENTIATION (2007)
Cdc7 is an active kinase in human cancer cells undergoing replication stress
Pierluigi Tenca et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
CDO kinase phosphorylates serine residues adjacent to acidic amino acids in the minichromosome maintenance 2 protein
Won-Ho Cho et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
A clinical drug library screen identifies astemizole as an antimalarial agent
Curtis R. Chong et al.
NATURE CHEMICAL BIOLOGY (2006)
Identification of Mcm2 phosphorylation sites by S-phase-regulating kinases
A Montagnoli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Assessment of ATM phosphorylation on Ser-1981 induced by DNA topoisomerase I and II inhibitors in relation to Ser-139-histone H2AX phosphorylation, cell cycle phase, and apoptosis
A Kurose et al.
CYTOMETRY PART A (2005)
A second human Dbf4/ASK-related protein, Drf1/ASKL1, is required for efficient progression of S and M phases
N Yoshizawa-Sugata et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Checking on DNA damage in S phase
J Bartek et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
Ataxia-telangiectasia-mutated (ATM) and NBS1-dependent phosphorylation of Chk1 on Ser-317 in response to ionizing radiation
M Gatei et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
DNA Damage Induced by DNA Topoisomerase I- and Topoisomerase II-Inhibitors Detected by Histone H2AXphosphorylation in Relation to the Cell Cycle Phase and Apoptosis
Xuan Huang et al.
CELL CYCLE (2003)
Human Dbf4/ASK promoter is activated through the Sp1 and MluI cell-cycle box (MCB) transcription elements
X Wu et al.
ONCOGENE (2002)
Drf1, a novel regulatory subunit for human Cdc7 kinase
A Montagnoli et al.
EMBO JOURNAL (2002)
ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1
H Zhao et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Caffeine abolishes the mammalian G2/M DNA damage checkpoint by inhibiting ataxia-telangiectasia-mutated kinase activity
BBS Zhou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
5-arylamino-2-methyl-4,7-dioxobenzothiazoles as inhibitors of cyclin-dependent kinase 4 and cytotoxic agents
CK Ryu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2000)
Role of quinones in toxicology
JL Bolton et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2000)
分享论文
